BIIB position history
The shares of Biogen (BIIB) that Hillman Capital Management, Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 28,289 shares, $8M, 2.8% of portfolio
- 2021 Q4: 27,191 shares, $6.5M, 2.2% of portfolio, Reduce −3.9%
- 2022 Q1: 42,679 shares, $9M, 2.9% of portfolio, Add +57.0%
- 2022 Q2: 43,019 shares, $8.8M, 3.2% of portfolio, Add +0.8%
- 2022 Q3: 31,754 shares, $8.5M, 3.5% of portfolio, Reduce −26.2%
- 2022 Q4: 30,076 shares, $8.3M, 3.3% of portfolio, Reduce −5.3%
- 2023 Q1: 29,536 shares, $8.2M, 3.1% of portfolio, Reduce −1.8%
- 2023 Q2: 29,411 shares, $8.4M, 3.0% of portfolio, Reduce −0.4%
- 2023 Q3: 34,306 shares, $8.8M, 3.4% of portfolio, Add +16.6%
- 2023 Q4: 34,476 shares, $8.9M, 3.1% of portfolio, Add +0.5%
- 2024 Q1: 35,792 shares, $7.7M, 2.5% of portfolio, Add +3.8%
- 2024 Q2: 35,954 shares, $8.3M, 2.9% of portfolio, Add +0.5%
- 2024 Q3: 35,253 shares, $6.8M, 2.3% of portfolio, Reduce −1.9%
- 2024 Q4: 43,066 shares, $6.6M, 2.4% of portfolio, Add +22.2%
- 2025 Q1: 44,025 shares, $6M, 3.0% of portfolio, Add +2.2%
- 2025 Q2: 41,972 shares, $5.3M, 2.9% of portfolio, Reduce −4.7%
- 2025 Q3: 38,354 shares, $5.4M, 3.1% of portfolio, Reduce −8.6%
- 2025 Q4: 30,516 shares, $5.4M, 3.4% of portfolio, Reduce −20.4%
- 2026 Q1: 29,540 shares, $5.4M, 3.8% of portfolio, Reduce −3.2%
- 2026 Q2: 23,993 shares, $5.2M, 3.8% of portfolio, Reduce −18.8%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|